Literature DB >> 32758415

Perinatal inflammation is associated with social and motor impairments in preterm children without severe neonatal brain injury.

Antoine Giraud1, Robin Chaux2, Marie-Julie Allard3, Magali Celle4, Georges Teyssier4, Frédéric Roche5, Céline Chapelle2, Stéphane Chabrier6, Guillaume Sébire3, Hugues Patural7.   

Abstract

OBJECTIVE: To test the association between exposure to perinatal inflammation - i.e. clinical chorioamnionitis or early-onset neonatal infection - in preterm children without severe neonatal brain injury and neurodevelopmental outcome at 30 months of corrected age (CA).
DESIGN: Cross-sectional study from a French regional cohort of clinical follow-up (SEVE Network). PATIENTS: One hundred sixty-four surviving neonates without severe brain injury - namely, grade III and IV cerebral hemorrhage and cystic periventricular leukomalacia - and without late-onset neonatal inflammation exposure - namely, late-onset neonatal infection and necrotizing enterocolitis -, born at less than 33 weeks of gestational age from November 2011 to June 2015 and enrolled in the SEVE Network. MAIN OUTCOME MEASURE: Global developmental quotient (DQ) score of the revised Brunet-Lézine scale and its four indices measured by the same neuropsychologist at 30 months of CA.
RESULTS: After multivariate analysis, exposure to perinatal inflammation was not found significantly associated with a modification of the global DQ score (coefficient -1.7, 95% CI -4.8 to 1.3; p = 0.26). Exposure to perinatal inflammation was associated with a decrease of the gross motor function DQ score (coefficient -6.0, 95% CI -9.9 to -2.1; p < 0.01) and a decrease of the sociability DQ score (coefficient -5.1, 95% CI -9.2 to -0.9; p = 0.02). Language and visuospatial coordination DQ scores were not affected by exposure to perinatal inflammation.
CONCLUSION: Exposure to perinatal inflammation in preterm children without severe neonatal brain injury is independently associated with decreased motor and social abilities at 30 months of CA.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Chorioamnionitis; Development; Early-onset neonatal infection; Prematurity; Revised Brunet-Lézine scale

Mesh:

Year:  2020        PMID: 32758415     DOI: 10.1016/j.ejpn.2020.06.008

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  4 in total

1.  COVID-19 Infection During Pregnancy Induces Differential Gene Expression in Human Cord Blood Cells From Term Neonates.

Authors:  Suhita Gayen Nee' Betal; Pedro Urday; Huda B Al-Kouatly; Kolawole Solarin; Joanna S Y Chan; Sankar Addya; Rupsa C Boelig; Zubair H Aghai
Journal:  Front Pediatr       Date:  2022-04-25       Impact factor: 3.569

2.  Uvaol Prevents Group B Streptococcus-Induced Trophoblast Cells Inflammation and Possible Endothelial Dysfunction.

Authors:  Ana Lucia Mendes Silva; Elaine Cristina Oliveira Silva; Rayane Martins Botelho; Liliane Patricia Gonçalves Tenorio; Aldilane Lays Xavier Marques; Ingredy Brunele Albuquerque Costa Rodrigues; Larissa Iolanda Moreira Almeida; Ashelley Kettyllem Alves Sousa; Keyla Silva Nobre Pires; Ithallo Sathio Bessoni Tanabe; Marie-Julie Allard; Guillaume Sébire; Samuel Teixeira Souza; Eduardo Jorge Silva Fonseca; Karen Steponavicius Cruz Borbely; Alexandre Urban Borbely
Journal:  Front Physiol       Date:  2021-12-03       Impact factor: 4.566

3.  The impact of perinatal inflammation on the electroencephalogram in preterm infants: a systematic review.

Authors:  Antoine Giraud; Carol M Stephens; Geraldine B Boylan; Brian H Walsh
Journal:  Pediatr Res       Date:  2022-04-01       Impact factor: 3.953

4.  Reelin cells and sex-dependent synaptopathology in autism following postnatal immune activation.

Authors:  Maryam Ardalan; Tetyana Chumak; Alexandra Quist; Eva Hermans; Ali Hoseinpoor Rafati; Giacomo Gravina; Seyedeh Marziyeh Jabbari Shiadeh; Pernilla Svedin; Setareh Alabaf; Brian Hansen; Gregers Wegener; Lars Westberg; Carina Mallard
Journal:  Br J Pharmacol       Date:  2022-05-23       Impact factor: 9.473

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.